How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease

Journal of Molecular Biology

Volumn 301, Issue 5, 2000, Pages 1207-1220

  Prabu Jeyabalan, Moses ^a   Nalivaika, Ellen ^a   Schiffer, Celia A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Crystallography; HIV 1 protease; Homodimer; Molecular recognition; Substrate specificity

Indexed keywords

EPITOPE; MONOMER; PROTEINASE; VIRUS ENZYME;

ARTICLE; COMPLEX FORMATION; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; ENZYME SPECIFICITY; ENZYME SUBSTRATE COMPLEX; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROGEN BOND; HYDROPHOBICITY; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; VIRUS CAPSID;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

EID: 0034283345     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2000.4018     Document Type: Article

References (45)

1. Inhibition of human immunodeficiency virus-1 protease by a C2-symmetric phosphinate. Synthesis and crystallographic analysis
2. Trans-dominant inhibitory human immunodeficiency virus type 1 protease monomers prevent protease activation and virion maturation
3. Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophyenylnorstatine
4. The protein data bank: A computer based archival file for macromolecular structures
5. Crystal structure of a tethered dimer of HIV-1 proteinase complexed with an inhibitor
6. The free R value: A novel statistical quantity for assessing the accuracy of crystal structures
7. Crystallography and NMR system: A new software suite for macromolecular structure determination
8. Predicting human immunodeficiency virus protease cleavage sites in proteins by a discriminant function method
9. Hydroxyethylene isostere inhibitors of human immunodeficency virus-1 protease: Structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays
10. Structural mechanisms of HIV drug resistance
11. The MIDAS display system
12. Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0 Å resolution
13. Energy calculations and analysis of HIV-1 protease-inhibitor crystal structures
14. Crystal structures of complexes of a peptidic inhibitor with wild-type and two mutant HIV-1 proteases
15. Influence of stereochemistry on activity and binding modes of C2 symmetry-based diol inhibitors of HIV-1 protease
16. Large scale purification and refolding of HIV-1 protease from Escherichia coli inclusion bodies
17. Structure of 2.5 Å resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor
18. Active human immunodeficiency virus protease is required for viral infectivity
19. Novel binding mode of highly potent HIV-proteinase inhibitors incorporating the (R)-hydroxyethylamine isostere
20. Crystal structures of the inactive D30N mutant of feline immunodeficiency virus protease complexed with a substrate and an inhibitor. Biochemistry
21. PROCHECK. A program to check the stereochemical quality of protein structures
22. Shape complementarity at protein/protein interfaces
23. The interpretation of protein structures: Estimation of static accessibility
24. Complete mutagenesis of the HIV-1 protease
25. Molecular recognition of macrocyclic peptidomimetic inhibitors by HIV-1 protease
26. Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 Å resolution
27. The crystal structures of 2.2 Å resolution of hydroxyethylene-based inhibitors bound to human immunodeficiency virus type 1 protease show that the inhibitors are present in two distinct orientations
28. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons
29. Comparative analysis of the X-ray structures of HIV-1 and HIV-2 proteases in complex with CGP 53820, a novel pseudosymmetric inhibitor
30. Conformation of polypeptides and proteins
31. Kinetics analysis of consecutive HIV proteolytic cleavages of the Gag-Pol polyprotein
32. HIV protease inhibitors: Their anti-HIV activity and potential role in treatment
33. Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity
34. Three dimensional structures of HIV-1 and SIV protease product complexes
35. Domain flexibility in retroviral proteases: Structural implications for drug resistant mutations
36. CHAIN - A crystallographic modeling program
37. Inhibition and catalytic mechanism of HIV-1 aspartic protease
38. X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor
39. Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: Comparisons with molecular modeling
40. Database of three-dimensional structures of HIV proteinases
41. Crystallographic analysis of human immunodeficiency virus 1 protease with an analog of the conserved CA-p2 substrate - Interactions with frequently occurring glutamic acid residue at P2' position of substrates
42. Structure-based inhibitors of HIV-1 protease
43. Conserved folding in retroviral proteases: Crystal structure of a synthetic HIV-1 protease